HOME >> BIOLOGY >> NEWS
UPMC Reports On New Liver Assist Device

rials in our patients," added George V. Mazariegos, M.D., assistant professor of surgery at the University of Pittsburgh Thomas E. Starzl Transplantation Institute.

The UPMC study presented results on an animal model of acute liver failure, comparing the performance of the Excorp device against standard treatment. The animals were divided into three treatment groups, one receiving standard intensive care attention, and the remaining two groups being placed on the bio-artificial liver assist device at either 16-18 hours or 24-26 hours after liver failure was initiated.

The report indicated survival times in the groups treated with the Excorp device could be extended. These results suggest that the bio-artificial liver assist device does in fact have a marked effect on the course of acute liver failure. The intercranial pressure also improved in the treated animals.

The anticipated phase I human trials of the device would have the primary aim of ensuring the safety of the device for human use. The researchers would monitor the clinical stability of patients, their neurological status, and development of infection. Researchers also hope to gain insight about the device's impact on treating liver failure, although a second trial would need to be conducted to thoroughly study its treatment efficacy.

"We are very encouraged by these preliminary findings," commented Dr. Mazariegos. "The need for some type of bridging device between liver recovery or transplantation is intense. This bio-artificial liver assist device may someday help the thousands of liver failure patients whose options are limited."

Acute liver failure can be caused by poisonous mushrooms, reactions to Tylenol toxicity, or as a result of a virus. There are currently more than 10,000 patients awaiting liver transplants in the United States. Less than five percent of the approximately
'"/>

Contact: Lisa Rossi
RossiL@a1.isd.upmc.edu
(412) 624-2607
University of Pittsburgh Medical Center
23-Apr-1998


Page: 1 2 3

Related biology news :

1. Reports of "weird life" almost stranger than fiction
2. Reports from special environmental health issue explore links to autoimmune diseases - diabetes, lupus, multiple scleroris and arthritis
3. Osiris Therapeutics Reports Key Findings in SCIENCE Verifying Existence of Adult Stem Cells
4. Abgenix Reports Encouraging Preclinical Results With ABX-EGF In Cancer Research
5. New England Journal Of Medicine Reports Calcium Supplements Help Prevent Polyp Recurrence; DMS Led Study
6. Duke Scientist Reports Advances In Gene Therapy For Heart Failure
7. North America Absorbing Carbon Dioxide At Surprisingly High Rate, Team Reports
8. University Of Pittsburgh Reports Novel Ways To Improve Transplant Acceptance At Transplantation Society Meeting
9. Cell Pathways Reports Extension Study Results Showing Ability Of FGN-1 To Prevent Formation Of Precancerous Colon Polyps
10. Reports Mesh To Clarify Proteins Importance For Cancer
11. Infant Dependency Drives Menopause, NSF-Supported Researcher Reports

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2019)... ... February 20, 2019 , ... ... that will see Dimensions rolled out across the organization. Dimensions provides in-depth ... across their business, support strategic planning, and understand past and future funding ...
(Date:2/19/2019)... (PRWEB) , ... February 19, 2019 , ... ... the appointment of Mark Hozza as Chief Commercial Officer of the life science ... responsible for the performance, strategy, and alignment of all market research and media ...
(Date:2/19/2019)... ... February 18, 2019 , ... ... and development solutions for drugs, biologics and consumer health products, today announced ... business partner recognition, the External Business Partner of the Year Award. , ...
Breaking Biology News(10 mins):
(Date:2/2/2019)... ... January 31, 2019 , ... Dust off your Doc Martens, Virun Nutra-BioSciences is ... 2019 Expo West Music and Tech Festival at the ESports Arena in Santa Ana ... natural foods, beverages, and dietary supplement industries, the Nuriv Music and Tech Festival is ...
(Date:2/2/2019)... ... 2019 , ... Biomatlante, a world leader in synthetic bone ... Dert, being effective on February 1st, 2019. , Graduated from ICN Business School, ... more than 12 years in the Medical Device industry. Chief Financial Officer of ...
(Date:1/30/2019)... DIEGO (PRWEB) , ... January 29, 2019 , ... ... integrated Contract Development and Manufacturing Organization (CDMO) serving the global biopharmaceutical and biotechnology ... A funding of $59.1 million backed by multiple global investors lead by China's ...
(Date:1/30/2019)... , ... January 29, 2019 , ... ... (AskBio), today announced the dosing of the first patient in a phase 1/2 ... a serious disease associated with high morbidity and often leads to premature death. ...
Breaking Biology Technology:
Cached News: